ADCT – Adc Therapeutics SA

Float Short %

3.51

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

0.04

EPS Last/This Y

0.21

EPS This/Next Y

0.34

Price

3.8

Target Price

Analyst Recom

Performance Q

-7.99

Relative Volume

0.45

Beta

1.94

Ticker: ADCT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ADCT	3.5	0.30	0.67	3047
2025-12-29	ADCT	3.51	0.30	0.00	3048
2025-12-30	ADCT	3.5	0.30	0.00	3053
2025-12-31	ADCT	3.54	0.30	999.99	3096
2026-01-02	ADCT	3.52	0.30	0.25	3095
2026-01-05	ADCT	3.56	0.30	0.00	3099
2026-01-06	ADCT	3.55	0.30	0.00	3099
2026-01-07	ADCT	3.65	0.28	0.00	3085
2026-01-08	ADCT	3.58	0.28	0.00	3085
2026-01-09	ADCT	3.65	0.27	0.00	3155
2026-01-12	ADCT	3.83	0.26	0.00	3252
2026-01-13	ADCT	3.7	0.25	0.00	3367
2026-01-14	ADCT	3.7	0.25	0.00	3367
2026-01-15	ADCT	3.54	0.25	0.00	3376
2026-01-16	ADCT	3.62	0.25	0.00	3377
2026-01-20	ADCT	3.53	0.05	0.00	1139
2026-01-21	ADCT	3.58	0.05	0.00	1144
2026-01-22	ADCT	3.81	0.05	0.00	1177
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ADCT	3.50	-	-	-1.41
2025-12-29	ADCT	3.51	-	-	-1.41
2025-12-30	ADCT	3.50	-	-	-1.41
2025-12-31	ADCT	3.54	-	-	-1.41
2026-01-02	ADCT	3.52	-	-	-1.41
2026-01-05	ADCT	3.56	-	-	-1.41
2026-01-06	ADCT	3.55	-	-	-1.41
2026-01-07	ADCT	3.65	-	-	-1.41
2026-01-08	ADCT	3.58	-	-	-1.41
2026-01-09	ADCT	3.65	-	-	-1.41
2026-01-12	ADCT	3.83	-	-	-1.41
2026-01-13	ADCT	3.70	-	-	-1.41
2026-01-14	ADCT	3.71	-	-	-1.41
2026-01-15	ADCT	3.54	-	-	-1.41
2026-01-16	ADCT	3.62	-	-	-1.41
2026-01-20	ADCT	3.53	-	-	-1.41
2026-01-21	ADCT	3.58	-	-	-1.41
2026-01-22	ADCT	3.80	-	-	-1.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ADCT	0.00	1.77	6.64
2025-12-29	ADCT	0.00	1.77	6.64
2025-12-30	ADCT	0.00	1.77	6.64
2025-12-31	ADCT	0.00	1.77	6.64
2026-01-02	ADCT	0.00	1.77	6.64
2026-01-05	ADCT	0.00	1.77	6.64
2026-01-06	ADCT	0.00	1.77	6.64
2026-01-07	ADCT	0.00	1.77	6.64
2026-01-08	ADCT	0.00	1.77	6.64
2026-01-09	ADCT	0.00	1.77	6.64
2026-01-12	ADCT	0.00	1.79	6.64
2026-01-13	ADCT	0.00	1.79	3.51
2026-01-14	ADCT	0.00	1.79	3.51
2026-01-15	ADCT	0.00	1.79	3.51
2026-01-16	ADCT	0.00	1.79	3.51
2026-01-20	ADCT	0.00	1.76	3.51
2026-01-21	ADCT	0.00	1.76	3.51
2026-01-22	ADCT	0.00	1.76	3.51
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

-0.3

Avg. EPS Est. Current Quarter

-0.29

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

Institutional Transactions

1.76

Beta

1.94

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-98.6

Target Price

P/E

Forward P/E

PEG

P/S

6.26

P/B

P/Free Cash Flow

EPS

-1.45

Average EPS Est. Cur. Y

-1.41

EPS Next Y. (Est.)

-1.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-221.97

Relative Volume

0.45

Return on Equity vs Sector %

42.8

Return on Equity vs Industry %

58.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.11

EBIT Estimation

ADC Therapeutics SA

Sector: Healthcare

Industry: Biotechnology

Employees: 263

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

stock quote shares ADCT – Adc Therapeutics SA Stock Price stock today

news today ADCT – Adc Therapeutics SA stock forecast ,stock prediction 2023 2024 2025

marketwatch ADCT – Adc Therapeutics SA yahoo finance google finance

stock history ADCT – Adc Therapeutics SA invest stock market

stock prices ADCT premarket after hours

ticker ADCT fair value insiders trading

CS – Credit Suisse Group AG

UBS – UBS Group AG

Float Short %

0.38

Margin Of Safety %

Put/Call OI Ratio

1.39

EPS Next Q Diff

0.03

EPS Last/This Y

1.41

EPS This/Next Y

0.19

Price

47.91

Target Price

44.52

Analyst Recom

2.55

Performance Q

27.56

Relative Volume

0.79

Beta

1.12

Ticker: UBS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	UBS	47.28	1.36	0.89	126549
2025-12-29	UBS	46.53	1.36	3.98	127065
2025-12-30	UBS	46.53	1.45	1.45	132860
2025-12-31	UBS	46.31	1.45	0.64	133132
2026-01-02	UBS	47.09	1.46	2.09	133495
2026-01-05	UBS	48.11	1.46	0.51	134166
2026-01-06	UBS	47.26	1.44	3.78	136368
2026-01-07	UBS	47.31	1.42	0.51	136315
2026-01-08	UBS	47.24	1.41	1.61	137691
2026-01-09	UBS	47.56	1.40	1.05	137436
2026-01-12	UBS	47.88	1.40	2.56	137558
2026-01-13	UBS	47.36	1.41	0.91	138230
2026-01-14	UBS	47.3	1.41	9.47	139107
2026-01-15	UBS	47.47	1.51	3.63	138437
2026-01-16	UBS	47.38	1.57	0.55	141319
2026-01-20	UBS	46.47	1.34	3.91	77906
2026-01-21	UBS	47.47	1.37	6.75	78981
2026-01-22	UBS	47.92	1.39	1.72	80297
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	UBS	47.28	64.5	-	3.00
2025-12-29	UBS	46.56	64.5	-	3.00
2025-12-30	UBS	46.53	64.5	-	3.00
2025-12-31	UBS	46.30	64.5	-	3.00
2026-01-02	UBS	47.09	64.5	-	3.00
2026-01-05	UBS	48.12	64.5	-	3.00
2026-01-06	UBS	47.26	64.5	-	3.00
2026-01-07	UBS	47.31	64.5	-	3.00
2026-01-08	UBS	47.23	64.5	-	3.00
2026-01-09	UBS	47.57	64.5	-	3.00
2026-01-12	UBS	47.88	64.5	-	3.00
2026-01-13	UBS	47.36	64.5	-	3.00
2026-01-14	UBS	47.30	64.5	-	3.00
2026-01-15	UBS	47.47	64.5	-	3.00
2026-01-16	UBS	47.37	64.5	-	3.00
2026-01-20	UBS	46.46	64.5	-	3.00
2026-01-21	UBS	47.46	64.5	-	3.00
2026-01-22	UBS	47.91	64.5	-	3.00
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	UBS	0.00	1.04	0.36
2025-12-29	UBS	0.00	1.04	0.36
2025-12-30	UBS	0.00	1.04	0.36
2025-12-31	UBS	0.00	1.04	0.36
2026-01-02	UBS	0.00	1.04	0.36
2026-01-05	UBS	0.00	1.06	0.36
2026-01-06	UBS	0.00	1.06	0.36
2026-01-07	UBS	0.00	1.06	0.36
2026-01-08	UBS	0.00	1.06	0.36
2026-01-09	UBS	0.00	1.06	0.36
2026-01-12	UBS	0.00	1.03	0.36
2026-01-13	UBS	0.00	1.03	0.37
2026-01-14	UBS	0.00	1.03	0.37
2026-01-15	UBS	0.00	1.03	0.37
2026-01-16	UBS	0.00	1.03	0.37
2026-01-20	UBS	0.00	1.01	0.38
2026-01-21	UBS	0.00	1.01	0.38
2026-01-22	UBS	0.00	1.01	0.38
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.76

Avg. EPS Est. Current Quarter

0.64

Avg. EPS Est. Next Quarter

0.79

Insider Transactions

Institutional Transactions

1.01

Beta

1.12

Average Sales Estimate Current Quarter

9875

Average Sales Estimate Next Quarter

10733

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

1.1

Max Drawdown 5-Year %

-32.5

Target Price

44.52

P/E

21.58

Forward P/E

PEG

0.4

P/S

1.88

P/B

1.66

P/Free Cash Flow

46.31

EPS

2.22

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

3.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.2

Relative Volume

0.79

Return on Equity vs Sector %

-3.4

Return on Equity vs Industry %

-2.6

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.34

EBIT Estimation

UBS Group AG Registered

Sector: Financial Services

Industry: Banks - Diversified

Employees: 108648

UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide. It operates through five divisions: Global Wealth Management, Personal & Corporate Banking, Asset Management, Investment Bank, and Non-core and Legacy. The company offers investment advice, estate and wealth planning, investing, corporate and banking, and investment management, as well as mortgage, securities-based, and structured lending solutions. It also provides personal banking products and services, such as deposits, credit and debit cards, and online and mobile banking, as well as lending, investments, retirement, and wealth management services; and corporate and institutional solutions, including equity and debt capital markets, syndicated and structured credit, private placements, leasing, traditional financing, and transaction banking solutions for payment and cash management services, trade and export finance, and global custody solutions. In addition, the company offers equities, fixed income, hedge funds, real estate and private markets, indexed and alternative beta strategies, asset allocation and currency investment strategies, customized multi-asset solutions, advisory and fiduciary services, and multi-manager hedge fund solutions and advisory services. Further, it advises clients on strategic business opportunities and helps them raise capital to fund their activities; enables its clients to buy, sell, and finance securities on capital markets and to manage risks and liquidity; distributes, trades in, finances, and clears cash equities and equity-linked products; structures, originates, and distributes new equity and equity-linked issues; and originates, distributes, manages risk, and provides liquidity in foreign exchange, rates, credit and precious metals. The company was formerly known as UBS AG and changed its name to UBS Group AG in December 2014. UBS Group AG was founded in 1862 and is headquartered in Zurich, Switzerland.

stock quote shares UBS – UBS Group AG Stock Price stock today

news today UBS – UBS Group AG stock forecast ,stock prediction 2023 2024 2025

marketwatch UBS – UBS Group AG yahoo finance google finance

stock history UBS – UBS Group AG invest stock market

stock prices UBS premarket after hours

ticker UBS fair value insiders trading

STM – STMicroelectronics N.V.

Float Short %

1.76

Margin Of Safety %

Put/Call OI Ratio

0.84

EPS Next Q Diff

-0.15

EPS Last/This Y

-1.03

EPS This/Next Y

0.42

Price

29.03

Target Price

31.46

Analyst Recom

2.17

Performance Q

-4.94

Relative Volume

0.7

Beta

1.58

Ticker: STM

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	STM	26.23	0.83	0.27	145564
2025-12-29	STM	26.02	0.83	1.33	145685
2025-12-30	STM	26.07	0.82	0.60	145061
2025-12-31	STM	25.93	0.82	0.30	145216
2026-01-02	STM	27.4	0.81	0.50	145824
2026-01-05	STM	27.4	0.78	0.84	147312
2026-01-06	STM	29.41	0.77	0.26	147725
2026-01-07	STM	28.87	0.76	1.58	151617
2026-01-08	STM	28.05	0.76	0.72	151973
2026-01-09	STM	28.83	0.76	0.52	153734
2026-01-12	STM	28.35	0.76	0.30	154755
2026-01-13	STM	28.42	0.75	0.54	155424
2026-01-14	STM	27.88	0.76	1.77	155875
2026-01-15	STM	28	0.77	1.55	156492
2026-01-16	STM	28.02	0.75	1.31	155981
2026-01-20	STM	27.11	0.86	0.43	105571
2026-01-21	STM	28.52	0.84	0.54	108218
2026-01-22	STM	29.02	0.84	0.13	111032
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	STM	26.22	-23.0	153.9	0.70
2025-12-29	STM	26.03	-23.0	149.6	0.70
2025-12-30	STM	26.06	-23.0	154.5	0.70
2025-12-31	STM	25.93	-23.0	133.0	0.70
2026-01-02	STM	27.39	-23.0	208.8	0.70
2026-01-05	STM	27.39	-23.0	163.3	0.70
2026-01-06	STM	29.39	-23.0	213.7	0.70
2026-01-07	STM	28.86	-23.0	195.9	0.70
2026-01-08	STM	28.05	-23.0	131.4	0.70
2026-01-09	STM	28.83	-23.0	209.6	0.70
2026-01-12	STM	28.34	-23.0	165.0	0.70
2026-01-13	STM	28.43	-23.0	186.1	0.70
2026-01-14	STM	27.88	-23.0	146.8	0.70
2026-01-15	STM	28.01	-23.0	177.8	0.70
2026-01-16	STM	28.04	-23.0	168.4	0.70
2026-01-20	STM	27.12	-23.0	141.7	0.70
2026-01-21	STM	28.52	-23.0	224.8	0.70
2026-01-22	STM	29.03	-23.0	202.1	0.70
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	STM	0	0.60	1.61
2025-12-29	STM	0	-5.70	1.61
2025-12-30	STM	0	-5.70	1.61
2025-12-31	STM	0	-5.70	1.61
2026-01-02	STM	0	-5.70	1.61
2026-01-05	STM	0	-14.05	1.61
2026-01-06	STM	0	-14.05	1.61
2026-01-07	STM	0	-14.05	1.61
2026-01-08	STM	0	-14.05	1.61
2026-01-09	STM	0	-14.05	1.61
2026-01-12	STM	0	-1.38	1.61
2026-01-13	STM	0	-1.38	1.74
2026-01-14	STM	0	-1.38	1.74
2026-01-15	STM	0	-1.38	1.74
2026-01-16	STM	0	-1.38	1.74
2026-01-20	STM	0	-15.47	1.74
2026-01-21	STM	0	-15.47	1.74
2026-01-22	STM	0	-15.47	1.76
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.29

Avg. EPS Est. Current Quarter

0.28

Avg. EPS Est. Next Quarter

0.14

Insider Transactions

Institutional Transactions

-15.47

Beta

1.58

Average Sales Estimate Current Quarter

3290

Average Sales Estimate Next Quarter

2919

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-66.7

Target Price

31.46

P/E

51.04

Forward P/E

26.01

PEG

5.79

P/S

2.2

P/B

1.44

P/Free Cash Flow

EPS

0.57

Average EPS Est. Cur. Y

0.7

EPS Next Y. (Est.)

1.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.51

Relative Volume

0.7

Return on Equity vs Sector %

-49.1

Return on Equity vs Industry %

-54.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

202.1

STMicroelectronics N.V.

Sector: Technology

Industry: Semiconductors

Employees: 49602

STMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and sells semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates through Analog products, MEMS and Sensors Group (AM&S); Power and Discrete products (P&D); Microcontrollers (MCU); and Digital ICs and RF Products (D&RF) segments. It offers industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); power management solutions; custom analog ICs, wireless charging solutions; galvanic isolated gate and LED drivers; converters, transistors, intelligent power switches, clocks and timers, comparators, and current-sense amplifiers; micro-electro-mechanical systems (MEMS) sensors, including accelerometers, gyroscopes, magnetic sensors, pressure, temperature, presence detection, biosensors, microphones, machine learning, and edge AI processing smart sensors, as well as thermal and piezoelectric actuators; and optical sensing solutions. The company also provides silicon MOSFETs, SiC MOSFETs, IGBTs, thyristors, rectifiers, and power modules and bipolar transistors; microcontrollers, NFC solutions, memories, and automotive MCUs; and radio frequency (RF) communications and ASICs, driver assistance systems, and RF and infotainment products. It serves automotive, industrial, personal electronics and communications equipment, and computers and peripherals markets. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Schiphol, the Netherlands.

stock quote shares STM – STMicroelectronics N.V. Stock Price stock today

news today STM – STMicroelectronics N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch STM – STMicroelectronics N.V. yahoo finance google finance

stock history STM – STMicroelectronics N.V. invest stock market

stock prices STM premarket after hours

ticker STM fair value insiders trading

SRAD – Sportradar Group AG

Float Short %

5.78

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

-0.04

EPS Last/This Y

0.27

EPS This/Next Y

0.09

Price

18.55

Target Price

32.49

Analyst Recom

1.18

Performance Q

-31.25

Relative Volume

2.94

Beta

2.03

Ticker: SRAD

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	SRAD	23.09	0.35	0.00	50282
2025-12-29	SRAD	23.42	0.33	0.21	52613
2025-12-30	SRAD	24.17	0.33	0.04	52944
2025-12-31	SRAD	23.78	0.33	0.08	53282
2026-01-02	SRAD	23.3	0.31	0.03	56117
2026-01-05	SRAD	23.04	0.29	0.03	59714
2026-01-06	SRAD	21.9	0.28	0.00	61428
2026-01-07	SRAD	21.04	0.24	2.49	68421
2026-01-08	SRAD	21.15	0.36	10.79	81135
2026-01-09	SRAD	20.91	0.53	0.23	92412
2026-01-12	SRAD	20.33	0.50	0.61	95814
2026-01-13	SRAD	19.99	0.46	0.08	98238
2026-01-14	SRAD	19.81	0.45	0.51	100008
2026-01-15	SRAD	19.82	0.44	0.18	100599
2026-01-16	SRAD	18.98	0.44	4.93	101439
2026-01-20	SRAD	18.63	0.57	2.93	101417
2026-01-21	SRAD	18.24	0.66	0.28	111028
2026-01-22	SRAD	18.55	0.65	0.31	112713
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	SRAD	23.08	1405.8	69.5	0.40
2025-12-29	SRAD	23.42	1405.8	73.9	0.40
2025-12-30	SRAD	24.17	1405.8	79.5	0.40
2025-12-31	SRAD	23.79	1405.8	65.2	0.40
2026-01-02	SRAD	23.32	1405.8	64.2	0.40
2026-01-05	SRAD	23.04	1405.8	66.3	0.40
2026-01-06	SRAD	21.98	1405.8	54.6	0.40
2026-01-07	SRAD	21.04	1405.8	55.7	0.40
2026-01-08	SRAD	21.23	1405.8	70.7	0.40
2026-01-09	SRAD	20.91	1405.8	63.9	0.40
2026-01-12	SRAD	20.33	1405.8	60.5	0.40
2026-01-13	SRAD	20.00	1405.8	63.2	0.40
2026-01-14	SRAD	19.85	1405.8	66.1	0.40
2026-01-15	SRAD	19.83	1405.8	68.0	0.40
2026-01-16	SRAD	18.98	1405.8	55.5	0.40
2026-01-20	SRAD	18.61	1405.8	62.6	0.40
2026-01-21	SRAD	18.24	1405.8	62.0	0.40
2026-01-22	SRAD	18.55	1405.8	73.5	0.40
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	SRAD	0.00	2.82	5.52
2025-12-29	SRAD	0.00	2.83	5.52
2025-12-30	SRAD	0.00	2.83	5.52
2025-12-31	SRAD	0.00	2.83	5.52
2026-01-02	SRAD	0.00	2.83	5.52
2026-01-05	SRAD	0.00	2.82	5.52
2026-01-06	SRAD	0.00	2.82	5.52
2026-01-07	SRAD	0.00	2.82	5.52
2026-01-08	SRAD	0.00	2.82	5.52
2026-01-09	SRAD	0.00	2.82	5.52
2026-01-12	SRAD	0.00	2.81	5.52
2026-01-13	SRAD	0.00	2.81	5.78
2026-01-14	SRAD	0.00	2.81	5.78
2026-01-15	SRAD	0.00	2.81	5.78
2026-01-16	SRAD	0.00	2.81	5.78
2026-01-20	SRAD	0.00	2.74	5.78
2026-01-21	SRAD	0.00	2.74	5.78
2026-01-22	SRAD	0.00	2.74	5.78
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.08

Avg. EPS Est. Current Quarter

0.1

Avg. EPS Est. Next Quarter

0.04

Insider Transactions

Institutional Transactions

2.74

Beta

2.03

Average Sales Estimate Current Quarter

369

Average Sales Estimate Next Quarter

371

Fair Value

24.72

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

42.4

Max Drawdown 5-Year %

Target Price

32.49

P/E

55.87

Forward P/E

32.03

PEG

0.33

P/S

4.26

P/B

4.96

P/Free Cash Flow

12.91

EPS

0.33

Average EPS Est. Cur. Y

0.4

EPS Next Y. (Est.)

0.48

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.84

Relative Volume

2.94

Return on Equity vs Sector %

-42.5

Return on Equity vs Industry %

-11.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

73.5

Sportradar Group AG

Sector: Technology

Industry: Software - Application

Employees: 4582

Sportradar Group AG, together with its subsidiaries, provides sports data services for the sports betting and media industries in Switzerland, the United States, North America, Africa, the Asia Pacific, the Middle East, Europe, Latin America, and the Caribbean. The company offers betting technology and solutions, including betting and gaming content; real-time sports data points; pre-match and live odds services; streaming and betting engagement services; iGaming, which includes virtual soccer, horse and dog racing, basketball, tennis, baseball, and cricket; managed betting and trading services; and sports betting and gaming platform. It also provides sports content, technology, and services that include marketing services; sports media services comprising data, content and solutions for broadcasters, publishers, rights-holders, and technology companies; integrity services, including monitoring, intelligence, education, consultancy, rights protection, and regulatory solutions; and sports performance solutions for competition management, official data generation, automated content distribution and performance analysis, which include video and analytics, and coaching and scouting products. Sportradar Group AG was founded in 2001 and is headquartered in Sankt Gallen, Switzerland.

stock quote shares SRAD – Sportradar Group AG Stock Price stock today

news today SRAD – Sportradar Group AG stock forecast ,stock prediction 2023 2024 2025

marketwatch SRAD – Sportradar Group AG yahoo finance google finance

stock history SRAD – Sportradar Group AG invest stock market

stock prices SRAD premarket after hours

ticker SRAD fair value insiders trading

ONON – On Holding AG

Float Short %

9.48

Margin Of Safety %

-3

Put/Call OI Ratio

0.54

EPS Next Q Diff

-0.14

EPS Last/This Y

-0.47

EPS This/Next Y

0.59

Price

46.61

Target Price

61.57

Analyst Recom

1.54

Performance Q

8.65

Relative Volume

0.41

Beta

2.16

Ticker: ONON

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-26	ONON	46.78	0.66	0.29	470190
2025-12-29	ONON	47.47	0.66	0.18	456474
2025-12-30	ONON	47.44	0.64	0.10	465211
2025-12-31	ONON	46.49	0.64	0.42	465977
2026-01-02	ONON	46.93	0.64	0.72	466825
2026-01-05	ONON	49	0.65	0.41	458770
2026-01-06	ONON	49.02	0.66	0.43	462291
2026-01-07	ONON	48.67	0.65	2.80	470486
2026-01-08	ONON	50.62	0.68	0.56	485467
2026-01-09	ONON	49.12	0.69	0.35	486144
2026-01-12	ONON	48.94	0.69	1.26	477063
2026-01-13	ONON	47.27	0.69	1.21	479892
2026-01-14	ONON	45.08	0.70	5.50	483724
2026-01-15	ONON	46	0.67	0.60	476400
2026-01-16	ONON	45.04	0.65	1.94	481692
2026-01-20	ONON	44.1	0.58	0.80	302880
2026-01-21	ONON	46.28	0.59	0.07	306991
2026-01-22	ONON	46.63	0.54	0.40	326804
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

18 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-26	ONON	46.78	-36.5	392.7	0.76
2025-12-29	ONON	47.47	-36.5	399.7	0.76
2025-12-30	ONON	47.44	-36.5	389.3	0.76
2025-12-31	ONON	46.48	-36.5	375.5	0.76
2026-01-02	ONON	46.96	-36.5	398.1	0.76
2026-01-05	ONON	48.98	-36.5	423.1	0.76
2026-01-06	ONON	49.03	-36.5	388.5	0.76
2026-01-07	ONON	48.67	-36.5	383.4	0.76
2026-01-08	ONON	50.62	-36.5	418.2	0.76
2026-01-09	ONON	49.13	-36.5	367.5	0.76
2026-01-12	ONON	48.91	-36.5	386.2	0.76
2026-01-13	ONON	47.28	-37.1	365.0	0.76
2026-01-14	ONON	45.08	-37.1	355.6	0.76
2026-01-15	ONON	46.01	-37.1	404.3	0.76
2026-01-16	ONON	45.06	-37.1	373.9	0.76
2026-01-20	ONON	44.11	-37.1	373.2	0.76
2026-01-21	ONON	46.28	-37.1	424.1	0.76
2026-01-22	ONON	46.61	-37.1	393.7	0.76
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

18 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-26	ONON	0.00	-4.86	8.96
2025-12-29	ONON	0.00	-4.90	8.96
2025-12-30	ONON	0.00	-4.90	8.96
2025-12-31	ONON	0.00	-4.90	8.96
2026-01-02	ONON	0.00	-4.90	8.96
2026-01-05	ONON	0.00	-4.95	8.96
2026-01-06	ONON	0.00	-4.95	8.96
2026-01-07	ONON	0.00	-4.95	8.96
2026-01-08	ONON	0.00	-4.95	8.96
2026-01-09	ONON	0.00	-4.95	8.96
2026-01-12	ONON	0.00	-4.98	8.96
2026-01-13	ONON	0.00	-4.98	9.52
2026-01-14	ONON	0.00	-4.98	9.52
2026-01-15	ONON	0.00	-4.98	9.52
2026-01-16	ONON	0.00	-4.98	9.52
2026-01-20	ONON	0.00	-4.76	9.48
2026-01-21	ONON	0.00	-4.76	9.48
2026-01-22	ONON	0.00	-4.76	9.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.42

Avg. EPS Est. Current Quarter

0.21

Avg. EPS Est. Next Quarter

0.28

Insider Transactions

Institutional Transactions

-4.76

Beta

2.16

Average Sales Estimate Current Quarter

721

Average Sales Estimate Next Quarter

853

Fair Value

45.34

Quality Score

Growth Score

100

Sentiment Score

Actual DrawDown %

27.2

Max Drawdown 5-Year %

Target Price

61.57

P/E

58.71

Forward P/E

29.29

PEG

1.55

P/S

4.53

P/B

7.95

P/Free Cash Flow

39.19

EPS

0.79

Average EPS Est. Cur. Y

0.76

EPS Next Y. (Est.)

1.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.77

Relative Volume

0.41

Return on Equity vs Sector %

-4.1

Return on Equity vs Industry %

-4.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

393.7

On Holding AG

Sector: Consumer Cyclical

Industry: Footwear & Accessories

Employees: 3254

On Holding AG engages in the development and distribution of sports products worldwide. The company offers athletic footwear, apparel, and accessories for high-performance running, outdoor, training, all-day activities, and tennis. It offers its products through independent retailers and distributors, online, and stores. The company was founded in 2010 and is headquartered in Zurich, Switzerland.

stock quote shares ONON – On Holding AG Stock Price stock today

news today ONON – On Holding AG stock forecast ,stock prediction 2023 2024 2025

marketwatch ONON – On Holding AG yahoo finance google finance

stock history ONON – On Holding AG invest stock market

stock prices ONON premarket after hours

ticker ONON fair value insiders trading

No more stocks to show

ADCT – Adc Therapeutics SA

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ADCT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

CS – Credit Suisse Group AG

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CS

No data found

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y